Renaissance Group’s AstraZeneca AZN Stock Holding History

Renaissance Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-190,852	Closed	-$13.4M	–	267
2014 Q4	$13.4M	Sell	190,852 -1,049	-0.5%	-$75.1K	0.52%	74
2014 Q3	$13.7M	Sell	191,901 -14,656	-7%	-$1.07M	0.54%	76
2014 Q2	$15.3M	Sell	206,557 -1,853	-0.9%	-$134K	0.59%	66
2014 Q1	$13.5M	Sell	208,410 -9,875	-5%	-$638K	0.54%	72
2013 Q4	$13M	Sell	218,285 -3,743	-2%	-$203K	0.52%	80
2013 Q3	$11.5M	Buy	222,028 +1,315	+0.6%	+$66K	0.49%	91
2013 Q2	$10.4M	Buy	+220,713	New	+$11.2M	0.47%	91

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Group's AZN Position: Q1 2015 in Review

Renaissance Group sold out of AstraZeneca (AZN) in Q1 2015, closing a stake of 190,852 shares — an estimated $13.4M sold.

Renaissance Group first reported a position in AZN in Q2 2013 and held it in 7 quarters. The position peaked at $15.3M in Q2 2014. 386 funds tracked by Wall St. Rank hold AZN as of Q1 2015.

Renaissance Group reported no remaining AstraZeneca position as of Q1 2015 after selling out during the quarter.
Renaissance Group sold 190,852 AstraZeneca shares in Q1 2015, an estimated $13.4M.
Renaissance Group first reported a position in AstraZeneca in Q2 2013 and held it in 7 quarters.
Renaissance Group's AstraZeneca position peaked at $15.3M in Q2 2014.
386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2015.

Based on Renaissance Group's 13F filing for Q1 2015, filed 6 May 2015.